Foresite Capital

Foresite Capital is a leading venture capital firm based in San Francisco, specializing in healthcare and life sciences investments. Founded in 2011 by Dr. Jim Tananbaum, the firm manages around $4 billion in assets. Foresite Capital is dedicated to transforming healthcare by funding innovative companies at all stages, from early to late-stage ventures. Notable investments include high-profile companies such as 10x Genomics, Element Biosciences, Lyell Immunopharma, Inscripta, Relay Therapeutics, and GRAIL. These companies leverage cutting-edge technologies in genomics, biotech, and precision medicine to advance healthcare solutions. Foresite Capital has a track record of success with over 37 IPOs and numerous acquisitions among its portfolio companies. Foresite Capital also operates Foresite Labs, an incubator for startups at the intersection of data science and healthcare, aiming to solve critical issues in therapeutics and healthcare services. This incubator is led by Dr. Vik Bajaj, former chief scientific officer of GRAIL and co-founder of Verily (formerly Google Life Sciences).